Who founded Melius Microbiomics?

Melius Microbiomics was founded by Dr. Deanna Gibson, Robert Emlyn, Celinka Zhou, Robert Emlyn, AScT, Celinka Zhou, M.Sc., Dr. Deanna L. Gibson, Ph.D. in 2023.

Who are Melius Microbiomics's investors?

Melius Microbiomics's investors include Innovation UBC.

Where is Melius Microbiomics headquartered?

Melius Microbiomics is headquartered in Vancouver, CA.

Melius Microbiomics

Vancouver, CA · Founded 2023 · 17 employees on LinkedIn · 1 known investors

Find your way into Melius Microbiomics

480 people in our graph share verified history with the Melius Microbiomics team — schools, employers, funds. One of them is your warm intro.

George Cigaleunlockedknows Robert Emlyn · together at Melius Microbiomics (overlapped)

knows the team · via Weyerhaeuser

knows the team · via Alector

×2knows the team · via Seres Therapeutics

×3knows the team · via Ferring Pharmaceuticals

knows the team · via The Johns Hopkins Hospital

Melius MicroBiomics develops microbiome-based live biotherapeutics (its GEMM technology) to treat chronic inflammatory diseases, pursuing both human and animal health applications. The company's therapies originate from patented research at the University of British Columbia Okanagan's Gibson Lab.

Biotech Healthtech Medical Devices

Founders & leadership

Dr. Deanna GibsonCo-Founder

Robert Emlyn Co-Founder & Chief Executive OfficerRobert Emlyn is a biotech entrepreneur who founded Innovate Phytotechnologies, a life sciences company focused on microbiome R&D and bioanalytical services, and previously led the development and sale of Innovate Clinical Centre. He is Co-Founder and CEO of Melius MicroBiomics, which develops microbiome-based live biotherapeutics to treat chronic inflammatory diseases.

Celinka ZhouCo-Founder & Executive VP, Corporate Development & Capital Markets

Robert Emlyn, AScT Co-Founder and Chief Executive OfficerRobert Emlyn founded and scaled Innovate Phytotechnologies, a life sciences firm focused on microbiome R&D and bioanalytical services, and previously led the sale of Innovate Clinical Centre in 2019. He is now Co-Founder and CEO of Melius MicroBiomics, which develops microbiome-based live biotherapeutics for chronic inflammatory diseases.

Celinka Zhou, M.Sc.Co-Founder & Executive VP, Corporate Development and Capital Markets

Dr. Deanna L. Gibson, Ph.D.Co-Founder & Non-Executive Chief Science Advisor

Kevin Horgan Head of Research & DevelopmentKevin Horgan is a physician-scientist with experience developing large and small molecule therapeutics across phases 1–4 in inflammation, immunology, CNS, and oncology at pharmaceutical and biotech companies. He holds expertise in microbiome science, AI applications, and diagnostics.

Investors · 1

Innovation UBClisted by Innovation UBCVancouver

How we know: Innovation UBC's portfolio page · Not right? Tell us

Frequently asked questions

What does Melius Microbiomics do?: Melius MicroBiomics develops microbiome-based live biotherapeutics (its GEMM technology) to treat chronic inflammatory diseases, pursuing both human and animal health applications. The company's therapies originate from patented research at the University of British Columbia Okanagan's Gibson Lab.
Who founded Melius Microbiomics?: Melius Microbiomics was founded by Dr. Deanna Gibson, Robert Emlyn, Celinka Zhou, Robert Emlyn, AScT, Celinka Zhou, M.Sc., Dr. Deanna L. Gibson, Ph.D. in 2023.
Who are Melius Microbiomics's investors?: Melius Microbiomics's investors include Innovation UBC.
Where is Melius Microbiomics headquartered?: Melius Microbiomics is headquartered in Vancouver, CA.